ClinicalTrials.Veeva

Menu

Efficacy and Safety of DA-9401 on Improvement of Sperm Motility

K

Korean Society for Sexual Medicine and Andrology

Status

Completed

Conditions

Spermatocele

Treatments

Dietary Supplement: DA-9401
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT03258437
DA-9401-SM

Details and patient eligibility

About

This study was conducted to investigate the effects of daily supplementation of Allium cepa L. and Cuscuta chinensis Lam. Extract Mixtures (DA-9401) on improvement of sperm motility.

Full description

This study was a 12 weeks, multi-center, randomized, double-blind, placebo-controlled human trial. Twenty subjects were randomly divided into Allium cepa L. and Cuscuta chinensis Lam. Extract Mixtures (DA-9401) or a placebo group. sperm motility profiles before and after the intervention.

Enrollment

27 patients

Sex

Male

Ages

20 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 20-55 years
  • sperm motility 40~69%

Exclusion criteria

  • History of alcohol or substance abuse
  • Participation in any other clinical trials within past 1 months
  • intense constipation

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

27 participants in 2 patient groups, including a placebo group

DA-9401
Experimental group
Description:
capsules (4cap/d, 2.16 g/d) for 12 weeks.
Treatment:
Dietary Supplement: DA-9401
Placebo
Placebo Comparator group
Description:
Placebo for 12 weeks.
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems